BioVector? p423-Gal 酵母表達(dá)質(zhì)粒載體

BioVector? p423-Gal Yeast Expression Vector

第一部分 中文說(shuō)明

一 載體基本信息與科研用途

• 載體名稱：BioVector? p423-Gal

• 載體類型：釀酒酵母（Saccharomyces cerevisiae）單拷貝/低拷貝穿梭表達(dá)質(zhì)粒載體。

• 核心用途：專門用于在釀酒酵母中實(shí)現(xiàn)外源目的基因的半乳糖嚴(yán)格誘導(dǎo)型、高精準(zhǔn)轉(zhuǎn)錄調(diào)控表達(dá)。

• 復(fù)制子與拷貝數(shù)：

  • 大腸桿菌：含有 pUC 復(fù)制子，表現(xiàn)為高拷貝。

  • 釀酒酵母：含有 CEN6/ARSH4 核心穿梭復(fù)制子元件。這是一種典型的著絲粒（Cen）型質(zhì)粒，在酵母細(xì)胞分裂過(guò)程中能夠像天然染色體一樣精準(zhǔn)地分配到子代細(xì)胞中，維持 1 到 2 個(gè)拷貝/細(xì)胞 的超低拷貝狀態(tài)。其最大優(yōu)勢(shì)在于有絲分裂穩(wěn)定性極高，且在不施加抗生素篩選壓力下也不易發(fā)生質(zhì)粒丟失。

• 抗性與選擇標(biāo)記：

  • 大腸桿菌篩選：氨芐青霉素抗性（Ampicillin，AmpR）。

  • 釀酒酵母篩選：帶有標(biāo)準(zhǔn)的 組氨酸營(yíng)養(yǎng)缺陷型選擇標(biāo)記（$HIS3$ 基因）。

• 常用宿主菌：大腸桿菌 DH5a、Top10 以及各類組氨酸缺陷型釀酒酵母底盤株（如 BY4741、INVSc1、W303-1A、AH109）。

二 關(guān)鍵結(jié)構(gòu)域與元件配置

• GAL1 嚴(yán)格誘導(dǎo)型啟動(dòng)子（GAL1 Promoter）：

  • 調(diào)控機(jī)制：該啟動(dòng)子受酵母內(nèi)源性半乳糖代謝網(wǎng)絡(luò)的極其嚴(yán)格控制。在以葡萄糖（Glucose）為碳源的培養(yǎng)基中，由于碳源分解代謝物阻遏效應(yīng)（Catabolite repression），GAL1 啟動(dòng)子的轉(zhuǎn)錄活性被徹底關(guān)閉（完全阻遏狀態(tài)）。當(dāng)將酵母細(xì)胞轉(zhuǎn)移至以非阻遏碳源（如精制棉子糖 Raffinose）生長(zhǎng)，并加入 D-半乳糖（D-Galactose） 作為誘導(dǎo)劑時(shí)，啟動(dòng)子被強(qiáng)效激活，驅(qū)動(dòng)下游目的基因爆發(fā)式轉(zhuǎn)錄。

  • 核心優(yōu)勢(shì)：適合用來(lái)表達(dá)對(duì)酵母具有高度毒性、嚴(yán)重阻礙細(xì)胞生長(zhǎng)或誘導(dǎo)宿主凋亡的異源不穩(wěn)定重組蛋白質(zhì)（先在葡萄糖中擴(kuò)增生物量，隨后切換至半乳糖短期高強(qiáng)度誘導(dǎo)表達(dá)）。

• 多克隆位點(diǎn)（MCS）：位于 GAL1 啟動(dòng)子正下方，集成了多種獨(dú)特的限制性內(nèi)切酶位點(diǎn)（如 BamHI, EcoRI, SalI, XhoI 等），便于目的片段的高效定向克隆。

• CYC1 終止子（CYC1 Terminator）：下游搭載細(xì)胞色素c1終止子，保障外源 mRNA 3端加工、多聚腺苷酸化（Polyadenylation）的精準(zhǔn)完成及轉(zhuǎn)錄的正常終止。

三 標(biāo)準(zhǔn)分子克隆與轉(zhuǎn)化操作步驟

1. 目的基因克隆：選用 MCS 中的合適酶切位點(diǎn)，將 PCR 擴(kuò)增的目的基因片段定向連接入 BioVector? p423-Gal 載體，轉(zhuǎn)化大腸桿菌并進(jìn)行定點(diǎn)酶切質(zhì)控與測(cè)序驗(yàn)證。

2. 酵母感受態(tài)制備與轉(zhuǎn)化：采用經(jīng)典的醋酸鋰（LiAc）/單鏈載體DNA（ssDNA）/聚乙二醇（PEG 3350）熱激法，將提取的高純度重組質(zhì)粒導(dǎo)入組氨酸缺陷型釀酒酵母（如 BY4741）中。

3. 陽(yáng)性轉(zhuǎn)化子篩選：將轉(zhuǎn)化后的酵母細(xì)胞懸液涂布于 BioVector? 酵母合成完全組氨酸缺陷型固體選擇培養(yǎng)基（SD/-His 培養(yǎng)基，以2%葡萄糖為碳源） 平板上，30攝氏度靜置培養(yǎng) 2 到 4 天，挑取長(zhǎng)出的單克隆。

4. 半乳糖誘導(dǎo)表達(dá)驗(yàn)證：

   • 種子液擴(kuò)增：將陽(yáng)性克隆接種于液體 SD/-His（含2%葡萄糖）中培養(yǎng)至對(duì)數(shù)生長(zhǎng)中后期。

   • 碳源適應(yīng)（可選）：離心收集細(xì)胞，用無(wú)菌水洗滌后，重懸于以 2% 棉子糖（Raffinose）為碳源的 -His 培養(yǎng)基中增殖 12 小時(shí)，以徹底消耗殘存的葡萄糖。

   • 爆發(fā)誘導(dǎo)：離心收集細(xì)胞，按 $O{D}_{600}=0.4$ 的起始密度重懸于含有 2% D-半乳糖（D-Galactose） 的 -His 誘導(dǎo)培養(yǎng)基中，30攝氏度繼續(xù)振蕩培養(yǎng) 12 到 24 小時(shí)，收集細(xì)胞生物量進(jìn)行 SDS-PAGE、Western Blot 或功能活性測(cè)定。

四 核心科研應(yīng)用方向

1. 酵母毒性蛋白/致死性基因的功能病理學(xué)解析：由于 GAL1 啟動(dòng)子在葡萄糖中的“零背景”阻遏特性，該載體是研究各類植物/動(dòng)物毒性蛋白（如朊病毒蛋白、細(xì)胞凋亡誘導(dǎo)因子 AIF、特定具有單向抑制作用的抗體片段）在酵母中胞內(nèi)表達(dá)與遺傳毒理的最理想控速系統(tǒng)。

2. 低拷貝穩(wěn)定多亞基復(fù)合物的重構(gòu)：利用 CEN 質(zhì)粒表現(xiàn)出的染色體級(jí)超高分離穩(wěn)定性和低拷貝特征（杜絕了 2微米 質(zhì)粒因拷貝數(shù)過(guò)高而導(dǎo)致的蛋白質(zhì)非特異性聚集和錯(cuò)誤折疊），與 p424-Gal（帶有 TRP1 標(biāo)記）、p425-Gal（帶有 LEU2 標(biāo)記）等系列載體并行使用，在同一酵母細(xì)胞中精準(zhǔn)共表達(dá)多聚體酶復(fù)合物的各個(gè)亞基。

3. 代謝途徑關(guān)鍵限速酶的劑量敏感性分析：用于在合成生物學(xué)路線中，以單拷貝級(jí)別微調(diào)特定外源代謝通路中限速步驟酶的轉(zhuǎn)錄通量，從而精確定量分析不同碳源流量切換下的產(chǎn)物產(chǎn)率變異，避免由高拷貝質(zhì)粒造成的代謝負(fù)擔(dān)過(guò)重（Metabolic burden）。

PART 2 ENGLISH SECTION

I General Information and Applications

• Vector Name: BioVector? p423-Gal

• Vector Type: Saccharomyces cerevisiae Low-Copy/Single-Copy Centromeric Shuttle Expression Vector.

• Primary Application: Engineered specifically for highly stringent, galactose-inducible, and low-fluctuation transcriptional control of heterologous target genes inside budding yeast.

• Replicon Infrastructure & Copy Number:

  • Escherichia coli: Outfitted with a high-copy pUC replication origin for high-yield plasmid preps.

  • Saccharomyces cerevisiae: Carries the distinct CEN6/ARSH4 centromeric shuttle replication assembly. This design behaves analogously to an autonomous mini-chromosome during yeast mitosis, maintaining a uniform, non-fluctuating baseline of 1 to 2 copies per cell. It provides excellent mitotic retention stability even across prolonged generations without continuous auxotrophic selection pressures.

• Selection Flags:

  • Bacterial Selection: Ampicillin resistance gene (AmpR) for propagation inside E. coli backbones.

  • Yeast Selection: Outfitted with the functional Histidine auxotrophic complementary marker (genuine $HIS3$ gene).

• Common Host Systems: E. coli DH5a, Top10, and any standard histidine-deficient Saccharomyces cerevisiae strains (e.g., BY4741, INVSc1, W303-1A, AH109).

II Vector Anatomy and Component Configuration

• GAL1 Stringent Inducible Promoter:

  • Regulatory Circuit: Driven by the host cell's endogenous galactose utilization network. When cultured in media formulated with glucose, the promoter is completely silenced and shut down through carbon catabolite repression pathways. Upon moving the biomass to non-repressing carbon configurations (such as refined Raffinose) and introducing D-Galactose, the repression is undone, activating transcription of the downstream open reading frame.

  • Core Technical Value: Highly prioritized for the successful cloning and expression of heterologous proteins that are highly toxic, cytostatic, or prone to initiating rapid autogenous cell death in yeast. It permits unhindered biomass expansion in glucose before triggering targeted protein synthesis.

• Multiple Cloning Site (MCS): Arranged directly underneath the GAL1 driving framework, incorporating unique restriction endpoints (such as BamHI, EcoRI, SalI, XhoI) for seamless, directional open reading frame integration.

• CYC1 Terminator: Positioned downstream of the MCS, utilizing the yeast Iso-1-cytochrome c terminator profile to command accurate mRNA 3'-end trimming, polyadenylation processing, and consistent elongation termination.

III Subcloning and Yeast Transformation Protocols

1. Target Subcloning: Excise the target open reading frame and integrate it directionally into compatible restriction sites within the dense MCS of BioVector? p423-Gal. Propagate the construct inside competent E. coli, verifying structural correctness via diagnostic restriction cuts and sequencing.

2. Yeast Competent Delivery: Utilize the standard Lithium Acetate (LiAc) / Single-Stranded Carrier DNA (ssDNA) / Polyethylene Glycol (PEG 3350) heat-shock protocol to transform the pure recombinant plasmid into a histidine-deficient yeast chassis (e.g., BY4741).

3. Auxotrophic Selection: Plate the transformed slurry directly onto BioVector? Synthetic Dextrose Histidine-Dropout agar plates (SD/-His solid agar supplemented with 2% glucose). Incubate undisturbed at 30 degrees Celsius for 2 to 4 days until robust complementary colonies emerge.

4. Galactose Induction Protocol:

   • Pre-Culture Phase: Inoculate a confirmed single colony into liquid SD/-His (with 2% glucose) and grow until mid-to-late log phase.

   • Repression Cleansing (Optional Step): Pellet the cells, wash away residual carbohydrate tracks with sterile water, and re-incubate the biomass in -His media made with 2% Raffinose for 12 hours to completely exhaust baseline internal glucose stores.

   • Target Induction Challenge: Harvest the cells and resuspend them at an initial seeding baseline of $O{D}_{600}=0.4$ in fresh synthetic induction broth containing 2% D-Galactose (as the sole carbon feed). Run the expression kinetics under continuous agitation at 30 degrees Celsius for 12 to 24 hours before processing the yeast pellet for SDS-PAGE, Western blot, or direct functional profiling.

IV Strategic Research Applications

1. Deciphering Functional Cascades of Yeast-Toxic and Lethal Targets: Thanks to the absolute zero-background repression profile of the GAL1 promoter under glucose, this vector serves as a premier research system to maintain, amplify, and then study volatile heterologous proteins (e.g., specific mammalian prions, apoptotic factors like AIF, or cytotoxic antibody formats) without suffering premature plasmid mutation or culture decay.

2. Reconstitution of Mitotically Stable Multi-Subunit Complexes: Utilizing its centromeric single-to-low copy distribution properties, it prevents the abnormal multi-protein aggregation or misfolding artifacts frequently caused by high-copy 2-micron vector formats. It is frequently multiplexed alongside complementary platforms like p424-Gal (TRP1 marker) or p425-Gal (LEU2 marker) to orchestrate balanced stoichiometric co-expression of multi-mer enzyme assemblies.

3. Dosage-Sensitivity Profiling in Synthetic Pathway Networks: Extensively deployed in synthetic biology pipelines to evaluate how strict low-copy transcriptional flux adjustments of rate-limiting pathway steps affect overall metabolic product yields. It helps optimize pathway balance while eliminating the severe metabolic burdens typically imposed by over-amplified high-copy vectors.